Psychiatry Research
Volume 153, Issue 2 , Pages 119-130 , 31 October 2007

Exophenotypical profile of adolescents with sustained attention deficit: A 10-year follow-up study

  • Eva M. Alvarez-Moya

      Affiliations

    • Psychopathology and Neuropsychology Research Unit, Department of Health Psychology, Autonomous University of Barcelona, Bellaterra, 08193, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Postal address: Unitat de Recerca en Psicopatologia i Neuropsicologia, Dept. Psicologia de la Salut, Facultat de Psicologia, Universitat Autonoma de Barcelona, Bellaterra, 08193, Barcelona, Spain. Tel.: +34 93 581 25 44; fax: +34 93 581 21 25.
    • ,
  • Neus Barrantes-Vidal

      Affiliations

    • Psychopathology and Neuropsychology Research Unit, Department of Health Psychology, Autonomous University of Barcelona, Bellaterra, 08193, Barcelona, Spain
    • ,
  • Jose Blas Navarro

      Affiliations

    • Methodology Unit, Department of Psychobiology and Methodology, Autonomous University of Barcelona, Bellaterra, 08193, Barcelona, Spain
    • ,
  • Susana Subira

      Affiliations

    • Psychopathology and Neuropsychology Research Unit, Department of Health Psychology, Autonomous University of Barcelona, Bellaterra, 08193, Barcelona, Spain
    • ,
  • Jordi E. Obiols

      Affiliations

    • Psychopathology and Neuropsychology Research Unit, Department of Health Psychology, Autonomous University of Barcelona, Bellaterra, 08193, Barcelona, Spain

Received 15 February 2006 ,Revised 26 July 2006 ,Accepted 15 December 2006.

References 

  1. Addington J. Cognitive functioning and negative symptoms in schizophrenia. In:  Sharma T,  Harvey P editor. Cognition in Schizophrenia: Impairments, Importance, and Treatment Strategies. New York: Oxford University Press; 2000;p. 193–209
  2. Alvarez-Moya, E.M., 2004. A 10-year longitudinal study of sustained attention across adolescence in a community sample: neurocognitive, personality, and biobehavioural correlates. Unpublished doctoral dissertation. Department of Health Psychology, Autonomous University of Barcelona, Barcelona, Spain.
  3. Barch DM, Mitropoulou V, Harvey PD, New AS, Silverman JM, Siever LJ. Context-processing deficits in schizotypal personality disorder. Journal of Abnormal Psychology. 2004;113:556–568
  4. Barrantes-Vidal, N., 2000. A follow-up study of an adolescent population sample at high neurocognitive risk for schizophrenia spectrum disorders. Unpublished doctoral dissertation. Health Psychology Department, Autonomous University of Barcelona, Barcelona, Spain.
  5. Barrantes-Vidal N, Fananas L, Rosa A, Caparros B, Dolors Riba M, Obiols JE. Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population. Schizophrenia Research. 2003;61:293–302
  6. Bartok E, Berecz R, Glaub T, Degrell I. Cognitive functions in prepsychotic patients. Progress in Neuropsychopharmacology and Biological Psychiatry. 2005;29:621–625
  7. Basso MR, Nasrallah HA, Olson SC, Bornstein RA. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research. 1998;31:99–111
  8. Bentall RP, Claridge GS, Slade PD. The multidimensional nature of schizotypal traits: a factor analytic study with normal subjects. British Journal of Clinical Psychology. 1989;28(Pt 4):363–375
  9. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. American Journal of Medical Genetics. 2003;123C:59–64
  10. Bleuler E. Dementia Praecox and the Group of Schizophrenias. New York: International Universities Press; 1950;
  11. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT. Attentional impairment in deficit and non-deficit forms of schizophrenia. American Journal of Psychiatry. 1997;154:363–370
  12. Buchsbaum MS, Haier RJ, Potkin S, Nuechterlein KH, Bracha HS, Katz M, et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry. 1992;49:935–942
  13. Buchsbaum MS, Nenadic I, Hazlett EA, Spiegel-Cohen J, Fleischman MB, Akhavan A, et al. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophrenia Research. 2002;54:141–150
  14. Burch GS, Steel C, Hemsley DR. Oxford-Liverpool Inventory of Feelings and Experiences: reliability in an experimental population. British Journal of Clinical Psychology. 1998;37(Pt 1):107–108
  15. Calkins ME, Curtis CE, Grove WM, Iacono WG. Multiple dimensions of schizotypy in first degree biological relatives of schizophrenia patients. Schizophrenia Bulletin. 2004;30:317–325
  16. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. Journal of Personality and Social Psychology. 1989;56:267–283
  17. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Pscyhology. 1994;103:171–183
  18. Chen WJ, Hsiao CK, Lin CCH. Schizotypy in community samples: the three-factor structure and correlation with sustained attention. Journal of Abnormal Psychology. 1997;106:649–654
  19. Claridge G, Beech T. Fully and Quasi-dimensional Constructions of Schizotypy. In:  Raine A,  Lencz T,  Mednick SA editor. Schizotypal Personality. New York: Cambridge University Press; 1995;p. 192–216
  20. Cohen RM, Nordahl TE, Semple WE, Andreason P, Pickar D. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Neuropsychopharmacology. 1998;19:36–47
  21. Cohen JD, Barch DM, Carter C, Servan-Schreiber D. Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. Journal of Abnormal Psychology. 1999;108:120–133
  22. Collins LM, Blanchard JJ, Biondo KM. Behavioral signs of schizoidia and schizotypy in social anhedonics. Schizophrenia Research. 2005;78:309–322
  23. Cornblatt BA. The New York high risk project to the Hillside recognition and prevention (RAP) program. American Journal of Medical Genetics. 2002;114:956–966
  24. Cornblatt BA, Keilp JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin. 1994;20:31–46
  25. Cornblatt BA, Malhotra AK. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. American Journal of Medical Genetics. 2001;105:11–15
  26. Cornblatt BA, Lenzenweger MR, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Research. 1989;29:65–85
  27. Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Developmental Psychopathology. 1999;11:487–508
  28. Cornblatt BA, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophrenia Research. 2002;54:177–186
  29. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin. 2003;29:633–651
  30. Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Morris J, et al. Sustained attention in young people at high risk for schizophrenia. Psychological Medicine. 2002;32:277–286
  31. Crespo M, Cruzado JA. La evaluación del afrontamiento: Adaptación española del cuestionario COPE con una muestra de estudiantes universitarios. Analisis y Modificacion de Conducta. 1997;23:797–830
  32. First MB, Spitzer RL, Gibbon M, Williams JBW, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II): II. Multi-site test–retest reliability. Journal of Personality Disorders. 1995;9:92–104
  33. First MB, Gibbon M, Spitzer RL, Williams JBW, Smith L. Guía del usuario para la Entrevista Clínica Estructurada para los Trastornos de la Personalidad del Eje II del DSM-IV. SCID-II (translated by Pérez and Sangorrín, 2001). Barcelona: Masson; 1997;
  34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders-Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997;
  35. Gooding DC, Tallent KA, Matts CW. Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy. Journal of Abnormal Psychology. 2005;114:170–175
  36. Gooding DC, Matts CW, Rollmann EA. Sustained attention deficits in relation to psychometrically identified schizotypy: evaluating a potential endophenotypic marker. Schizophrenia Research. 2006;82:27–37
  37. Goodman R. Developmental disorders and structural brain development. In:  Rutter M,  Casaer P editor. Biological Risk Factors for Psychosocial Disorders. Cambridge, England: Cambridge University Press; 1991;p. 20–49
  38. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry. 2003;160:636–645
  39. Hambrecht M, Lammertink M, Klosterkotter J, Matuschek E, Pukrop R. Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. British Journal of Psychiatry. Supplement. 2002;43:s30–s37
  40. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, Van Os J. How psychotic are individuals with non-psychotic disorders?. Social Psychiatry and Psychiatric Epidemiology. 2003;38:149–154
  41. Hollis C, Taylor E. Schizophrenia: a critique from the developmental psychopathology perspective. In:  Keshavan MS,  Murray RM editor. Neurodevelopment and Adult Psychopathology. Cambridge: Cambridge University Press; 1997;p. 213–234
  42. Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh high-risk study. British Journal of Psychiatry. 2005;186:18–25
  43. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry. 1993;50:527–540
  44. Kwapil TR. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. Journal of Abnormal Psychology. 1998;107:558–565
  45. Kwapil TR, Miller MB, Zinser MC, Chapman J, Champan LJ. Magical ideation and social anhedonia as predictors of psychosis proneness: a partial replication. Journal of Abnormal Psychology. 1997;106:491–495
  46. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research. 2004;68:37–48
  47. Lenzenweger MF, Cornblatt BA, Putnick ME. Schizotypy and sustained attention. Journal of Abnormal Psychology. 1991;100:84–89
  48. Loranger AW, Susman VL, Oldham JM, Russakoff LM. The Personality Disorder Examination: a preliminary report. Journal of Personality Disorders. 1987;1:1–13
  49. Lysaker PH, Wilt MA, Plascak-Hallberg CD, Brenner CA, Clements CA. Personality dimensions in schizophrenia: associations with symptoms and coping. Journal of Nervous and Mental Disease. 2003;191:80–86
  50. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O, et al. Continuity and discontinuity of affective disorders and schizophrenia: results of a controlled family study. Archives of General Psychiatry. 1993;50:871–883
  51. Maric N, Krabbendam L, Vollebergh W, de Graaf R, Van Os J. Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophrenia Research. 2003;63:89–95
  52. Mason O, Claridge G. The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophrenia Research. 2006;82:203–211
  53. Mason O, Claridge G, Jackson M. New scales for the assessment of schizotypy. Personality and Individual Differences. 1995;18:7–13
  54. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophrenia Research. 2004;71:227–237
  55. Matsui M, Sumiyoshi T, Kato K, Yoneyama E, Kurachi M. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia. Psychological Reports. 2004;94:387–397
  56. McGorry PD, Yung AR, Phillips LJ. The “close-in” or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin. 2003;29:771–790
  57. Meehl PE. Schizotaxia, schizotypy, schizophrenia. American Psychologist. 1962;17:827–838
  58. Meehl PE. Schizotaxia revisited. Archives of General Psychiatry. 1989;46:935–944
  59. Meehl PE. Toward an integrated theory of schizotaxia, schizotypy and schizophrenia. Journal of Personality Disorders. 1990;4:1–99
  60. Meyer TD, Hautzinger M. Prediction of personality disorder traits by psychosis proneness scales in a German sample of young adults. Journal of Clinical Psychology. 2002;58:1091–1101
  61. Miller P, Byrne M, Hodges A, Lawrie SM, Owens DG, Johnstone EC. Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study. British Journal of Psychiatry. 2002;180:179–184
  62. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder?. British Medical Journal. 1987;295:681–682
  63. Murray RM, O'Callahan E, Castle DJ, Lewis SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin. 1992;18:319–332
  64. Niemi LT, Suvisaari JM, Haukka JK, Lonnqvist JK. Childhood predictors of future psychiatric morbidity in offspring of mothers with psychotic disorder: results from the Helsinki High-Risk Study. British Journal of Psychiatry. 2005;186:108–114
  65. Nuechterlein KH. Signal detection in vigilance tasks and behavioural attributes among offspring of schizophrenic mothers and among hyperactive children. Journal of Abnormal Psychology. 1983;92:4–28
  66. Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, et al. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophrenia Research. 2002;54:121–130
  67. Obiols JE, García M, de Trinchería I, Doménech E. Psychometric schizotypy and sustained attention in young males. Personality and Individual Differences. 1993;14:381–384
  68. Obiols JE, Serrano F, Barrantes N, García-Marimón M, Gras S, Bosch E, et al. Frontal dysfunction and psychosis proneness in CPT-linked vulnerable adolescents. Personality and Individual Differences. 1997;23:677–683
  69. Obiols JE, Serrano F, Caparros B, Subira S, Barrantes N. Neurological soft signs in adolescents with poor performance on the continous performance test: markers of liability for schizophrenia spectrum disorders?. Psychiatry Research. 1999;86:217–228
  70. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. American Journal of Psychiatry. 2002;159:1855–1861
  71. Peralta V, Cuesta MJ. Factor structure and clinical validity of competing models of positive symptoms in schizophrenia. Biological Psychiatry. 1998;44:107–114
  72. Peralta V, Cuesta MJ, de Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biological Psychiatry. 1994;36:726–736
  73. Rosa A, van Os J, Fananas L, Barrantes N, Caparros B, Gutierrez B, et al. Developmental instability and schizotypy. Schizophrenia Research. 2000;43:125–134
  74. Rosanoff AJ, Handy LM, Rosanoff-Plesset I, Brush S. The etiology of so-called schizophrenic psychoses. American Journal of Psychiatry. 1934;91:247–286
  75. Schuldberg D, Karwacki SB, Burns GL. Stress, coping, and social support in hypothetically psychosis-prone subjects. Psychological Reports. 1996;78:1267–1283
  76. Servan-Schreiber D, Cohen JD, Steingard S. Schizophrenic deficits in the processing of context. A test of a theoretical model. Archives of General Psychiatry. 1996;53:1105–1112
  77. Siever LJ, Koenigsberg HW, Harvey P, Mitropoulou V, Laruelle M, Abi-Dargham A, et al. Cognitive and brain function in schizotypal personality disorder. Schizophrenia Research. 2002;54(1–2):157–167(54, 157–167)
  78. Silva F. Assessing the child and adolescent personality: a decade of research. Personality and Individual Differences. 1992;13:1163–1181
  79. Silva F, Moro M, Ortet G. Dimensiones de orientación interpersonal: un modelo y un instrumento. In:  Garaigordobil M,  Maganto C editor. Socialización y conducta prosocial en la infancia y en la adolescencia. San Sebastian, Spain: Servicio Editorial de la Universidad del País Vasco; 1994;p. 89–108
  80. Silva F, Martínez- Arias R, Moro M, Ortet G. Dimensions of interpersonal orientation: description and construct validation of the Spanish Assessment Kit. European Psychology. 1996;1:187–199
  81. Silva F, Martínez-Arias R, Rapaport E, Ertle A, Ortet G. Dimensions of interpersonal orientation: cross-cultural studies regarding the structure of the “DOI Kit”. Personality and Individual Differences. 1997;23:973–985
  82. Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychological Medicine. 2002;32:347–358
  83. Strauss JS. Hallucinations and delusions as points on continua function. Archives of General Psychiatry. 1969;21:581–586
  84. Tsuang MT. Defining alternative phenotypes for genetic studies: what can we learn from studies of schizophrenia?. American Journal of Medical Genetics. 2001;105:8–10
  85. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophrenia Research. 2002;54:169–175
  86. Tsuang MT, Stone WS, Gamma F, Faraone SV. Schizotaxia: current status and future directions. Current Psychiatry Reports. 2003;5:128–134
  87. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. Validating schizotaxia and its place in studies of preventing schizophrenia by psychopharmacological intervention. Essential Psychopharmacology. 2005;6:91–103
  88. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, et al. A comparison of the utility of dimensional and categorical representations of psychosis UK700 Group. Psychological Medicine. 1999;29:595–606
  89. Van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophrenia Research. 2000;45:11–20
  90. Verdoux H, Maurice-Tison S, Gay B, Van Os J, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychological Medicine. 1998;28:127–134
  91. Voglmaier MM, Seidman LJ, Niznikiewicz MA, Dickey CC, Shenton ME, McCarley RW. A comparative profile analysis of neuropsychological function in men and women with schizotypal personality disorder. Schizophrenia Research. 2005;74:43–49
  92. Vollema MG, Postma B. Neurocognitive correlates of schizotypy in first degree relatives of schizophrenia patients. Schizophrenia Bulletin. 2002;28:367–377
  93. Wilder-Willis KE, Shear PK, Steffen JJ, Borkin J. The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophrenia Research. 2002;55:259–267
  94. Wood SJ, Pantelis C, Proffitt T, Phillips LJ, Stuart GW, Buchanan JA, et al. Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine. 2003;33:1239–1247
  95. Zanarini MC, Skodol AE, Bender D, Dolan R, Sanislow C, Schaefer E, et al. The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. Journal of Personality Disorders. 2000;14:291–299

PII: S0165-1781(06)00411-2

doi: 10.1016/j.psychres.2006.12.021

Psychiatry Research
Volume 153, Issue 2 , Pages 119-130 , 31 October 2007

Article Tools

* Image Usage & Resolution